{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:23:03Z","timestamp":1786123383267,"version":"build-2736575974"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1213\/ane.0000000000000249","type":"journal-article","created":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T10:13:10Z","timestamp":1400235190000},"page":"196-202","source":"Crossref","is-referenced-by-count":29,"title":["Ph\u03b11\u03b2, a Peptide from the Venom of the Spider Phoneutria Nigriventer Shows Antinociceptive Effects after Continuous Infusion in a Neuropathic Pain Model in Rats"],"prefix":"10.1213","volume":"119","author":[{"given":"Fernanda","family":"Rosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fl\u00e1via Karine","family":"Rigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Tonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edin\u00e9ia Lemos","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"do Nascimento Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Batista","family":"Calixto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Vin\u00edcius","family":"Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliano","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-28-20210902","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1212\/01.wnl.0000282763.29778.59","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes.","volume":"70","author":"Treede","year":"2008","journal-title":"Neurology"},{"key":"R2-28-20210902","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pain.2010.07.031","article-title":"NeuPSIG guidelines on neuropathic pain assessment.","volume":"152","author":"Haanpaa","year":"2011","journal-title":"Pain"},{"key":"R3-28-20210902","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.pain.2007.08.013","article-title":"Prevalence of chronic pain with neuropathic characteristics in the general population.","volume":"136","author":"Bouhassira","year":"2008","journal-title":"Pain"},{"key":"R5-28-20210902","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0091270010394852","article-title":"Efficacy of antidepressants as analgesics: a review.","volume":"52","author":"Dharmshaktu","year":"2012","journal-title":"J Clin Pharmacol"},{"key":"R6-28-20210902","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.2337\/dc07-2105","article-title":"Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses.","volume":"31","author":"Freeman","year":"2008","journal-title":"Diabetes Care"},{"key":"R7-28-20210902","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1034\/j.1600-0404.2000.0006a.x","article-title":"Gabapentin use in neuropathic pain syndromes.","volume":"101","author":"Nicholson","year":"2000","journal-title":"Acta Neurol Scand"},{"key":"R8-28-20210902","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1254\/jphs.08319FP","article-title":"A mouse model of sural nerve injury-induced neuropathy: gabapentin inhibits pain-related behaviors and the hyperactivity of wide-dynamic range neurons in the dorsal horn.","volume":"109","author":"Omori","year":"2009","journal-title":"J Pharmacol Sci"},{"key":"R9-28-20210902","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1212\/01.wnl.0000244422.45278.ff","article-title":"Pregabalin in central neuropathic pain associated with spinal cord injury: a placebo-controlled trial.","volume":"67","author":"Siddall","year":"2006","journal-title":"Neurology"},{"key":"R10-28-20210902","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1359-6446(05)03662-7","article-title":"Targeting N-type and T-type calcium channels for the treatment of pain.","volume":"11","author":"McGivern","year":"2006","journal-title":"Drug Discov Today"},{"key":"R11-28-20210902","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.291.1.63","article-title":"Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS: a randomized controlled trial.","volume":"291","author":"Staats","year":"2004","journal-title":"JAMA"},{"key":"R12-28-20210902","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev.pa.35.040195.003423","article-title":"Antagonists of neuronal calcium channels: structure, function, and therapeutic implications.","volume":"35","author":"Miljanich","year":"1995","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R14-28-20210902","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0304-3959(99)00254-7","article-title":"Adverse effects associated with the intrathecal administration of ziconotide.","volume":"85","author":"Penn","year":"2000","journal-title":"Pain"},{"key":"R15-28-20210902","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2147\/TCRM.S4438","article-title":"Safety and efficacy of intrathecal ziconotide in the management of severe chronic pain.","volume":"5","author":"Smith","year":"2009","journal-title":"Ther Clin Risk Manag"},{"key":"R16-28-20210902","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.toxicon.2011.09.008","article-title":"Antiallodynic effect and side effects of Ph1, a neurotoxin from the spider Phoneutria nigriventer: comparison with -conotoxin MVIIA and morphine.","volume":"58","author":"de Souza","year":"2011","journal-title":"Toxicon"},{"key":"R17-28-20210902","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pain.2008.07.014","article-title":"Analgesic effect in rodents of native and recombinant Ph alpha 1beta toxin, a high-voltage-activated calcium channel blocker isolated from armed spider venom.","volume":"140","author":"Souza","year":"2008","journal-title":"Pain"},{"key":"R18-28-20210902","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.pain.2011.04.015","article-title":"Antinociceptive effect of Brazilian armed spider venom toxin Tx3-3 in animal models of neuropathic pain.","volume":"152","author":"Dalmolin","year":"2011","journal-title":"Pain"},{"key":"R19-28-20210902","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s10571-012-9871-x","article-title":"An evaluation of the antinociceptive effects of Ph1, a neurotoxin from the spider Phoneutria nigriventer, and -conotoxin MVIIA, a cone snail Conus magus toxin, in rat model of inflammatory and neuropathic pain.","volume":"33","author":"de Souza","year":"2013","journal-title":"Cell Mol Neurobiol"},{"key":"R20-28-20210902","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals.","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"key":"R21-28-20210902","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0041-0101(93)90354-L","article-title":"Purification and amino acid sequences of six Tx3 type neurotoxins from the venom of the Brazilian armed spider Phoneutria nigriventer (Keys).","volume":"31","author":"Cordeiro Mdo","year":"1993","journal-title":"Toxicon"},{"key":"R22-28-20210902","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man.","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"R23-28-20210902","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw.","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"key":"R24-28-20210902","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations.","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R25-28-20210902","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1523\/JNEUROSCI.14-08-04882.1994","article-title":"Voltage-sensitive calcium channels in spinal nociceptive processing: blockade of N- and P-type channels inhibits formalin-induced nociception.","volume":"14","author":"Malmberg","year":"1994","journal-title":"J Neurosci"},{"key":"R26-28-20210902","first-page":"233","article-title":"The mandate for a proper preservation in histopathological tissues.","volume":"53","author":"Comanescu","year":"2012","journal-title":"Rom J Morphol Embryol"},{"key":"R27-28-20210902","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/08977150252806947","article-title":"Development and characterization of a novel, graded model of clip compressive spinal cord injury in the mouse: Part 1. Clip design, behavioral outcomes, and histopathology.","volume":"19","author":"Joshi","year":"2002","journal-title":"J Neurotrauma"},{"key":"R28-28-20210902","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/1056-8719(94)90087-6","article-title":"A method to perform direct transcutaneous intrathecal injection in rats.","volume":"32","author":"Mestre","year":"1994","journal-title":"J Pharmacol Toxicol Methods"},{"key":"R29-28-20210902","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0022-3565(25)21283-6","article-title":"Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain.","volume":"279","author":"Bowersox","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"R30-28-20210902","doi-asserted-by":"crossref","first-page":"F1223","DOI":"10.1152\/ajprenal.00535.2010","article-title":"TRPA1 receptor modulation attenuates bladder overactivity induced by spinal cord injury.","volume":"300","author":"Andrade","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"R32-28-20210902","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.pain.2006.10.019","article-title":"Voltage-gated calcium channels and pain.","volume":"126","author":"Cao","year":"2006","journal-title":"Pain"},{"key":"R33-28-20210902","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2174\/157340606778250216","article-title":"N-type calcium channel blockers: novel therapeutics for the treatment of pain.","volume":"2","author":"Schroeder","year":"2006","journal-title":"Med Chem"},{"key":"R34-28-20210902","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.jpain.2005.09.007","article-title":"Calcium channels as therapeutic targets in neuropathic pain.","volume":"7","author":"Yaksh","year":"2006","journal-title":"J Pain"},{"key":"R35-28-20210902","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.brainresrev.2008.12.021","article-title":"Role of voltage-gated calcium channels in ascending pain pathways.","volume":"60","author":"Zamponi","year":"2009","journal-title":"Brain Res Rev"},{"key":"R36-28-20210902","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1602\/neurorx.2.4.662","article-title":"Targeting chronic and neuropathic pain: the N-type calcium channel comes of age.","volume":"2","author":"Snutch","year":"2005","journal-title":"NeuroRx"},{"key":"R37-28-20210902","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1744-8069-8-15","article-title":"Translational investigation and treatment of neuropathic pain.","volume":"8","author":"Xu","year":"2012","journal-title":"Mol Pain"},{"key":"R38-28-20210902","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00002508-199709000-00012","article-title":"Use of intrathecal SNX-111, a novel, N-type, voltage-sensitive, calcium channel blocker, in the management of intractable brachial plexus avulsion pain.","volume":"13","author":"Brose","year":"1997","journal-title":"Clin J Pain"},{"key":"R39-28-20210902","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0304-3959(99)00214-6","article-title":"Interactions of intrathecally administered ziconotide, a selective blocker of neuronal N-type voltage-sensitive calcium channels, with morphine on nociception in rats.","volume":"84","author":"Wang","year":"2000","journal-title":"Pain"},{"key":"R40-28-20210902","doi-asserted-by":"crossref","first-page":"35335","DOI":"10.1074\/jbc.M002252200","article-title":"Novel omega-conotoxins from Conus catus discriminate among neuronal calcium channel subtypes.","volume":"275","author":"Lewis","year":"2000","journal-title":"J Biol Chem"},{"key":"R41-28-20210902","doi-asserted-by":"crossref","first-page":"20171","DOI":"10.1074\/jbc.M300581200","article-title":"Determinants of inhibition of transiently expressed voltage-gated calcium channels by omega-conotoxins GVIA and MVIIA.","volume":"278","author":"Feng","year":"2003","journal-title":"J Biol Chem"},{"key":"R42-28-20210902","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/j.1526-4637.2011.01118.x","article-title":"Intravenous injection of leconotide, an omega conotoxin: synergistic antihyperalgesic effects with morphine in a rat model of bone cancer pain.","volume":"12","author":"Kolosov","year":"2011","journal-title":"Pain Med"},{"key":"R43-28-20210902","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1124\/jpet.105.087023","article-title":"Inhibition of high voltage-activated calcium channels by spider toxin PnTx3-6.","volume":"314","author":"Vieira","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R44-28-20210902","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0306-4522(90)90318-X","article-title":"Effect of omega conotoxin on reflex responses mediated by activation of capsaicin-sensitive nerves of the rat urinary bladder and peptide release from the rat spinal cord.","volume":"34","author":"Maggi","year":"1990","journal-title":"Neuroscience"},{"key":"R45-28-20210902","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2165\/00003495-199141030-00002","article-title":"Opioid agonist-antagonist drugs in acute and chronic pain states.","volume":"41","author":"Hoskin","year":"1991","journal-title":"Drugs"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1213\/ANE.0000000000000249","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:35:15Z","timestamp":1786113315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201407000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000000249","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}